| First Author | Schor JS | Year | 2022 |
| Journal | Elife | Volume | 11 |
| PubMed ID | 35786442 | Mgi Jnum | J:327140 |
| Mgi Id | MGI:7328236 | Doi | 10.7554/eLife.75253 |
| Citation | Schor JS, et al. (2022) Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice. Elife 11:e75253 |
| abstractText | Subthalamic nucleus deep brain stimulation (STN DBS) relieves many motor symptoms of Parkinson's disease (PD), but its underlying therapeutic mechanisms remain unclear. Since its advent, three major theories have been proposed: (1) DBS inhibits the STN and basal ganglia output; (2) DBS antidromically activates motor cortex; and (3) DBS disrupts firing dynamics within the STN. Previously, stimulation-related electrical artifacts limited mechanistic investigations using electrophysiology. We used electrical artifact-free GCaMP fiber photometry to investigate activity in basal ganglia nuclei during STN DBS in parkinsonian mice. To test whether the observed changes in activity were sufficient to relieve motor symptoms, we then combined electrophysiological recording with targeted optical DBS protocols. Our findings suggest that STN DBS exerts its therapeutic effect through the disruption of movement-related STN activity, rather than inhibition or antidromic activation. These results provide insight into optimizing PD treatments and establish an approach for investigating DBS in other neuropsychiatric conditions. |
